Skip to main content

. 1969 Jul 5;3(5661):55. doi: 10.1136/bmj.3.5661.55-b

Drug treatment of thyrotoxicosis.

D A Montgomery, D C Lowe, R G Shanks, J A Weaver

PMCID: PMC1983789 PMID: 4892039

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

LEE W. Y., BRONSKY D., WALDSTEIN S. S. Studies of thyroid and sympathetic nervous system interrelationships. II. Effects of guanethidine on manifestations of hyperthyroidism. J Clin Endocrinol Metab. 1962 Sep;22:879–885. doi: 10.1210/jcem-22-9-879. [DOI] [PubMed] [Google Scholar]
Parsons V., Jewitt D. Beta-adrenergic blockade in the management of acute thyrotoxic crisis, tachycardia and arrhythmias. Postgrad Med J. 1967 Dec;43(506):756–762. doi: 10.1136/pgmj.43.506.756. [DOI] [PMC free article] [PubMed] [Google Scholar]
Shanks R. G., Hadden D. R., Lowe D. C., McDevitt D. G., Montgomery D. A. Controlled trial of propranolol in thyrotoxicosis. Lancet. 1969 May 17;1(7603):993–994. doi: 10.1016/s0140-6736(69)91797-8. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES